Terbinafine

Product NDC
76282-209
11-digit product format
762820209
Labeler code
76282
Product ID
76282-209_dc86cdd6-0a8a-4e5c-b3c4-8b05388af862
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Terbinafine
Dosage form
TABLET
Route
ORAL
Labeler
Exelan Pharmaceuticals Inc.
Application
ANDA077533
Marketing category
ANDA
Marketing start
2012-04-25
Substance
TERBINAFINE HYDROCHLORIDE
Active strength
250 mg/1
Pharmacologic classes
Allylamine Antifungal [EPC], Allylamine [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Terbinafine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TERBINAFINE HYDROCHLORIDE250 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii012C11ZU6G
Rxcui313222

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
55a24767-1759-5f6a-8888-ea4aa0adac21Product name120140508
db9701af-cb4f-b8ba-d282-6bc5b6b7c467Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76282-209-01Terbinafine100 in 1 BOTTLETABLET1006
76282-209-05Terbinafine500 in 1 BOTTLETABLET5006
76282-209-30Terbinafine30 in 1 BOTTLETABLET306

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
76282-209-30EA - Each76282-209452dd277-21e7-41b5-9c7c-a498a4a1e01b12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TERBINAFINE HYDROCHLORIDEACTIVE INGREDIENT012C11ZU6GTERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1
TERBINAFINEACTIVE MOIETYG7RIW8S0XPTERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOTERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30TERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4TERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2TERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76282-209TERBINAFINE TABLET [EXELAN PHARMACEUTICALS INC.]6Current NDC, Legacy NDC, 3 package rows20201102_6dc279cc-9861-4fa8-8083-ca3b3c57b513.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313222terbinafine HCl 250 MG Oral TabletPSN6dc279cc-9861-4fa8-8083-ca3b3c57b5136
313222terbinafine 250 MG Oral TabletSCD6dc279cc-9861-4fa8-8083-ca3b3c57b5136
313222terbinafine (as terbinafine HCl) 250 MG Oral TabletSY6dc279cc-9861-4fa8-8083-ca3b3c57b5136

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
76282-209-0176282020901100 TABLET in 1 BOTTLE (76282-209-01) 100 tablet2012-04-250000-00-00NoNoCurrent
76282-209-0576282020905500 TABLET in 1 BOTTLE (76282-209-05) 500 tablet2012-04-250000-00-00NoNoCurrent
76282-209-307628202093030 TABLET in 1 BOTTLE (76282-209-30) 30 tablet2012-04-250000-00-00NoNoCurrent